EP2714678 - IMIDAZOLE DERIVATIVES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 25.07.2014 Database last updated on 07.06.2024 | Most recent event Tooltip | 08.08.2014 | Change - extension states | published on 10.09.2014 [2014/37] | Applicant(s) | For all designated states Intervet International B.V. Wim de Körverstraat 35 5831 AN Boxmeer / NL | [2014/15] | Inventor(s) | 01 /
DE VITA, Robert, J. 332 W. Dudley Avenue New Jersey Westfield 07090 / US | 02 /
HONG, QingMei 126 E. Lincoln Avenue Rahway, NJ / US | 03 /
LAI, Zhong 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 04 /
DYKSTRA, Kevin, D. 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 05 /
YU, Yang 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 06 /
LIU, Jian 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 07 /
SPERBECK, Donald 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 08 /
JIAN, Tianying 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 09 /
GUIADEEN, Deodial 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 10 /
XU-QIANG YANG, Ginger 1540 Raspberry Court Edison, NJ 08817 / US | 11 /
WU, Zhicai 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 12 /
HE, Shuwen 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 13 /
TING, Pauline, C. 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 14 /
ASLANIAN, Robert 144 Phillip Drive Rockaway, NJ 07866 / US | 15 /
KUETHE, Jeffrey, T. 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 16 /
BALKOVEC, James, M. 2144 Gilbride Road Martinsville, NJ 08836 / US | 17 /
KUANG, Rongze 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 18 /
ZHOU, Gang 126 E. Lincoln Avenue Rahway, NJ 07065 / US | 19 /
WU, Heping 126 E. Lincoln Avenue Rahway, NJ 07065 / US | [2014/15] | Representative(s) | Janssen, Paulus J. P. Merck Sharp & Dohme Ltd. European Patents Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | [N/P] |
Former [2014/15] | Janssen, Paulus J. P. Merck Sharp & Dohme Ltd. Hertford Road Hoddesdon, Hertfordshire EN11 9BU / GB | Application number, filing date | 12725727.7 | 01.06.2012 | WO2012EP60381 | Priority number, date | US201161492428P | 02.06.2011 Original published format: US 201161492428 P | [2014/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012164071 | Date: | 06.12.2012 | Language: | EN | [2012/49] | Type: | A1 Application with search report | No.: | EP2714678 | Date: | 09.04.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.12.2012 takes the place of the publication of the European patent application. | [2014/15] | Search report(s) | International search report - published on: | EP | 06.12.2012 | Classification | IPC: | C07D401/14, C07D405/14, C07D413/14, C07D417/14, A61K31/4188, A61P3/00 | [2014/15] | CPC: |
C07D401/14 (EP,CN,US);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
C07D405/14 (EP,CN,US);
C07D413/14 (EP,CN,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/15] | Title | German: | IMIDAZOLDERIVATE | [2014/15] | English: | IMIDAZOLE DERIVATIVES | [2014/15] | French: | DÉRIVÉS D'IMIDAZOLE | [2014/15] | Entry into regional phase | 02.01.2014 | National basic fee paid | 02.01.2014 | Designation fee(s) paid | 02.01.2014 | Examination fee paid | Examination procedure | 22.11.2013 | Amendment by applicant (claims and/or description) | 02.01.2014 | Examination requested [2014/15] | 22.07.2014 | Application withdrawn by applicant [2014/35] | Fees paid | Renewal fee | 31.03.2014 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2008039008 (KOREA RES INST OF BIOSCIENCE [KR], et al) [A] 1-20 * See claim 1; the examples *; | [A]WO2009005672 (MERCK & CO INC [US], et al) [A] 1-20* See claim 1; the examples * | by applicant | WO9804528 | WO9901423 | US6054587 | WO0039088 | US6110903 | WO0069810 | US6284748 | WO0208188 | US6399782 | WO02060388 | US6489476 | WO03104207 | US6699871 | WO2004019869 | WO2004020409 | WO2004020408 | US6730690 | WO2004058741 | WO2004066963 | WO2009000087 | WO2009011836 | WO2009042053 | - Journal of Japan Society for the Study of Obesity, (2006), vol. 12 | - PROG. LIPID RES., (2004), vol. 43, pages 134 - 176 | - ANN. MED., (2004), vol. 36, pages 252 - 261 | - PROC. NATL. ACAD. SCI. USA., (1998), vol. 95, pages 13018 - 13023 | - JBC, (2001), vol. 276, pages 38870 - 38876 | - JBC, (2005), vol. 280, pages 21506 - 21514 | - NATURE GENETICS, (2000), vol. 25, pages 87 - 90 | - JCI, (2002), vol. 109, pages 1049 - 1055 | - JCI, (2003), vol. 111, pages 1715 - 1722 | - DIABETES, (2004), vol. 53, pages 1445 - 1451 | - DIABETES, (2002), vol. 51, pages 3189 - 3195 | - DIABETES, (2005), vol. 54, pages 3379 - 3386 | - S. CHAKI ET AL., "Recent advances in feeding suppressing agents: potential therapeutic strategy for the treatment of obesity", EXPERT OPIN. THER. PATENTS, (2001), vol. 11, doi:doi:10.1517/13543776.11.11.1677, pages 1677 - 1692, XP002438303 DOI: http://dx.doi.org/10.1517/13543776.11.11.1677 | - D. SPANSWICK; K. LEE, "Emerging antiobesity drugs", EXPERT OPIN. EMERGING DRUGS, (2003), vol. 8, doi:doi:10.1517/eoed.8.1.217.21037, pages 217 - 237, XP008028338 DOI: http://dx.doi.org/10.1517/eoed.8.1.217.21037 | - J.A. FERNANDEZ-LOPEZ ET AL., "Pharmacological Approaches for the Treatment of Obesity", DRUGS, (2002), vol. 62, doi:doi:10.2165/00003495-200262060-00005, pages 915 - 944, XP009001892 DOI: http://dx.doi.org/10.2165/00003495-200262060-00005 | - K.M. GADDE ET AL., "Combination pharmaceutical therapies for obesity", EXP. OPIN. PHARMACOTHER, (2009), vol. 10, pages 921 - 925 | - AVRAM ET AL., CHEMISCHE BERICHTE, (1957), vol. 90, page 1424,1427 |